EUVIMEDEUVIMED entdecken
Crossref

INDIVIDUAL ARTICLE: Tirbanibulin 1% Ointment: The Mechanism of Action of a Novel Topical Therapy for Actinic Keratosis

Alyssa M Roberts, Leon Kircik, Mark Lebwohl, April W Armstrong

Journal of Drugs in Dermatology · 2025

DOI: 10.36849/jdd.19913 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Drugs in Dermatology, 2025. Verfasst von Alyssa M Roberts und 3 weiteren Autor:innen. Hauptthemen laut MEDLINE: Dermatologic Agents, Keratosis, Actinic. Die Arbeit wurde bisher 3-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatologic AgentsKeratosis, ActinicHumansAdministration, CutaneousApoptosisCarcinoma, Squamous CellKeratinocytesOintmentsSkin NeoplasmsTreatment Outcome

Substanzen

Dermatologic AgentsOintments

Zitieren

APA

Roberts, A. M., Kircik, L., Lebwohl, M., & Armstrong, A. W. (2025). INDIVIDUAL ARTICLE: Tirbanibulin 1% Ointment: The Mechanism of Action of a Novel Topical Therapy for Actinic Keratosis. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.19913

Vancouver

Roberts AM, Kircik L, Lebwohl M, Armstrong AW. INDIVIDUAL ARTICLE: Tirbanibulin 1% Ointment: The Mechanism of Action of a Novel Topical Therapy for Actinic Keratosis. Journal of Drugs in Dermatology. 2025. doi:10.36849/jdd.19913

BibTeX
@article{Roberts2025,
  author = {Roberts, Alyssa M and Kircik, Leon and Lebwohl, Mark and Armstrong, April W},
  title = {INDIVIDUAL ARTICLE: Tirbanibulin 1% Ointment: The Mechanism of Action of a Novel Topical Therapy for Actinic Keratosis},
  journal = {Journal of Drugs in Dermatology},
  year = {2025},
  doi = {10.36849/jdd.19913}
}
Kostenlos starten →